165 related articles for article (PubMed ID: 27061445)
1. Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry.
Ohlmeier C; Langner I; Garbe E; Riedel O
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):778-84. PubMed ID: 27061445
[TBL] [Abstract][Full Text] [Related]
2. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.
Ohlmeier C; Langner I; Hillebrand K; Schmedt N; Mikolajczyk R; Riedel O; Garbe E
BMC Public Health; 2015 Jun; 15():570. PubMed ID: 26087768
[TBL] [Abstract][Full Text] [Related]
3. Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry.
Langner I; Ohlmeier C; Zeeb H; Haug U; Riedel O
BMJ Open; 2019 Jul; 9(7):e028223. PubMed ID: 31270118
[TBL] [Abstract][Full Text] [Related]
4. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
6. Record linkage of claims and cancer registries data-Evaluation of a deterministic linkage approach based on indirect personal identifiers.
Kollhorst B; Reinders T; Grill S; Eberle A; Intemann T; Kieschke J; Meyer M; Nennecke A; Rathmann W; Pigeot I
Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1287-1293. PubMed ID: 36129372
[TBL] [Abstract][Full Text] [Related]
7. Describing the linkages of the immigration, refugees and citizenship Canada permanent resident data and vital statistics death registry to Ontario's administrative health database.
Chiu M; Lebenbaum M; Lam K; Chong N; Azimaee M; Iron K; Manuel D; Guttmann A
BMC Med Inform Decis Mak; 2016 Oct; 16(1):135. PubMed ID: 27769227
[TBL] [Abstract][Full Text] [Related]
8. Two approaches to linking census and hospital data.
Rotermann M; Sanmartin C; Carrière G; Trudeau R; St-Jean H; Saïdi A; Reicker A; Ntwari A; Hortop E
Health Rep; 2014 Oct; 25(10):3-14. PubMed ID: 25317754
[TBL] [Abstract][Full Text] [Related]
9. [Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states].
Pigeot I; Bongaerts B; Eberle A; Katalinic A; Kieschke J; Luttmann S; Meyer M; Nennecke A; Rathmann W; Stabenow R; Wilsdorf-Köhler H; Kollhorst B; Reinders T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 May; 65(5):615-623. PubMed ID: 34940893
[TBL] [Abstract][Full Text] [Related]
10. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
11. Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data.
Oppelt KA; Luttmann S; Kraywinkel K; Haug U
BMC Med Res Methodol; 2019 Jul; 19(1):142. PubMed ID: 31286896
[TBL] [Abstract][Full Text] [Related]
12. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
[TBL] [Abstract][Full Text] [Related]
13. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
14. Using personal health insurance numbers to link the Canadian Cancer Registry and the Discharge Abstract Database.
Zakaria D; Trudeau R; Sanmartin C; Murison P; Carrière G; MacIntyre M; Turner D; Wagar B; King MJ; Vriends K; Woods R; Lockwood G; Louchini R
Health Rep; 2015 Jun; 26(6):3-11. PubMed ID: 26086334
[TBL] [Abstract][Full Text] [Related]
15. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
Becher H; Kostev K; Schröder-Bernhardi D
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
[TBL] [Abstract][Full Text] [Related]
16. [Enrichment of Claims Data with Official Causes of Death Using a Record Linkage with the Epidemiological Cancer Registry of North Rhine-Westphalia: Feasibility Study and Comparison of Procedures].
Langner I; Krieg V; Heidinger O; Hense HW; Zeeb H
Gesundheitswesen; 2019 Aug; 81(8-09):629-635. PubMed ID: 29390198
[TBL] [Abstract][Full Text] [Related]
17. [The Bremen mortality index].
Giersiepen K; Brünings-Kuppe C; Lehmann C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 May; 47(5):451-6. PubMed ID: 15205758
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of algorithms to identify incident cancer cases by using French health administrative databases.
Ajrouche A; Estellat C; De Rycke Y; Tubach F
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):935-944. PubMed ID: 28485129
[TBL] [Abstract][Full Text] [Related]
19. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
[TBL] [Abstract][Full Text] [Related]
20. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
